Zeitschrift für Zellsignalisierung

Zeitschrift für Zellsignalisierung
Offener Zugang

ISSN: 2576-1471

Abstrakt

Immuno-oncology Therapies

Vikram Kumar

These therapies are measured as to be promising anti-cancer treatments and treatments and generating excitement and hope among clinicians, patients and researchers. The torrent of ion portfolio of immune oncology next generation sequencing (NGS) enables multi-dimensional and ground-breaking approach to understanding the microenvironment tumor. Each assay about genomic uses the sensitivity of NGS to hidden biology within precious samples and can be independently implemented or combined more holistic view to improve positively impact study ouCDomes and clinical research study design.

Top